DIADEXUS, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • November 9th, 2011 • diaDexus, Inc. • Pharmaceutical preparations • California
This Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between Brian Ward (“Executive”) and diaDexus, Inc. (the “Company”), effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”).
ContractWarrant Agreement • November 9th, 2011 • diaDexus, Inc. • Pharmaceutical preparations • California
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY APPLICABLE STATE SECURITIES LAWS, AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF ARTICLE 4 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS, OR PURSUANT TO RULE 144 OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.
DIADEXUS, INC. STOCK OPTION AGREEMENTStock Option Agreement • November 9th, 2011 • diaDexus, Inc. • Pharmaceutical preparations • Delaware
diaDexus, Inc., a Delaware corporation (the “Company”) hereby grants to the holder listed below (“Optionee”), an option to purchase the number of shares of the Company’s Common Stock set forth below (the “Option”), subject to all of the terms and conditions of this Stock Option Agreement (“Agreement”).
diaDexus, Inc. LOAN AND SECURITY AGREEMENTLoan and Security Agreement • November 9th, 2011 • diaDexus, Inc. • Pharmaceutical preparations • California
This LOAN AND SECURITY AGREEMENT (this “Agreement”) is entered into as of September 23, 2011, by and between Comerica Bank (“Bank”) and diaDexus, Inc. (“Borrower”).
TRANSITION AND SEPARATION AGREEMENTTransition and Separation Agreement • November 9th, 2011 • diaDexus, Inc. • Pharmaceutical preparations • California
This Transition and Separation Agreement (the “Agreement”) is made by and between Robert Wolfert (“Executive”) and diaDexus, Inc., a Delaware corporation (the “Company”), effective as of eighth day following the date Executive signs this Agreement (the “Effective Date”) with reference to the following facts:
SEPARATION AGREEMENTSeparation Agreement • November 9th, 2011 • diaDexus, Inc. • Pharmaceutical preparations • California
This Separation Agreement (the “Agreement”) is made by and between Bernard M. Alfano (“Executive”) and diaDexus, Inc., a Delaware corporation (the “Company”), effective as of eighth day following the date Executive signs this Agreement (the “Effective Date”) with reference to the following facts:
CONSULTING AGREEMENTConsulting Agreement • November 9th, 2011 • diaDexus, Inc. • Pharmaceutical preparations • California
This Consulting Agreement (“Agreement”) is made and entered into as of September 22, 2011 James Panek, (“Effective Date”) by and between diaDexus, Inc. located at 343 Oyster Point Boulevard, South San Francisco, CA 94080 (“Company”), and James Panek, 120 Valdeflores Drive, Burlingame, CA 94010 (“Consultant”). The Company desires to retain Consultant as an independent contractor to perform consulting services for the Company and Consultant is willing to perform such services, on the terms set forth more fully below. In consideration of the mutual promises contained herein, the parties agree as follows:
